Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John Chu is active.

Publication


Featured researches published by John Chu.


Journal of the American Chemical Society | 2008

A Single-Molecule Nanopore Device Detects DNA Polymerase Activity with Single-Nucleotide Resolution

Scott L. Cockroft; John Chu; Manuel Amorín; M. Reza Ghadiri

The ability to monitor DNA polymerase activity with single-nucleotide resolution has been the cornerstone of a number of advanced single-molecule DNA sequencing concepts. Toward this goal, we report the first observation of the base-by-base DNA polymerase activity with single-base resolution at the single-molecule level. We describe the design and characterization of a supramolecular nanopore device capable of detecting up to nine consecutive DNA polymerase-catalyzed single-nucleotide primer extensions with high sensitivity and spatial resolution (<or=2.4 A). The device is assembled in a suspended lipid membrane by threading and mechanically capturing a single strand of DNA-PEG copolymer inside an alpha-hemolysin protein pore. Single-nucleotide primer extensions result in successive displacements of the template DNA strand within the protein pore, which can be monitored by the corresponding stepped changes in the ion current flowing through the pore under an applied transmembrane potential. The system described thus represents a promising advance toward nanopore-mediated single-molecule DNA sequencing concept and, in addition, might be applicable to studying a number of other biopolymer-protein interactions and dynamics.


Nature | 2016

Amide-directed photoredox-catalysed C–C bond formation at unactivated sp 3 C–H bonds

John Chu; Tomislav Rovis

Carbon–carbon (C–C) bond formation is paramount in the synthesis of biologically relevant molecules, modern synthetic materials and commodity chemicals such as fuels and lubricants. Traditionally, the presence of a functional group is required at the site of C–C bond formation. Strategies that allow C–C bond formation at inert carbon–hydrogen (C–H) bonds enable access to molecules that would otherwise be inaccessible and the development of more efficient syntheses of complex molecules. Here we report a method for the formation of C–C bonds by directed cleavage of traditionally non-reactive C–H bonds and their subsequent coupling with readily available alkenes. Our methodology allows for amide-directed selective C–C bond formation at unactivated sp3 C–H bonds in molecules that contain many such bonds that are seemingly indistinguishable. Selectivity arises through a relayed photoredox-catalysed oxidation of a nitrogen–hydrogen bond. We anticipate that our findings will serve as a starting point for functionalization at inert C–H bonds through a strategy involving hydrogen-atom transfer.


Nature | 2017

Commensal bacteria make GPCR ligands that mimic human signalling molecules

Louis J. Cohen; Daria Esterhazy; Seong-Hwan Kim; Christophe Lemetre; Rhiannon R. Aguilar; Emma A. Gordon; Amanda J. Pickard; Justin R. Cross; Ana B. Emiliano; Sun M. Han; John Chu; Xavier Vila-Farres; Jeremy Kaplitt; Aneta Rogoz; Paula Y. Calle; Craig P. Hunter; J. Kipchirchir Bitok; Sean F. Brady

Commensal bacteria are believed to have important roles in human health. The mechanisms by which they affect mammalian physiology remain poorly understood, but bacterial metabolites are likely to be key components of host interactions. Here we use bioinformatics and synthetic biology to mine the human microbiota for N-acyl amides that interact with G-protein-coupled receptors (GPCRs). We found that N-acyl amide synthase genes are enriched in gastrointestinal bacteria and the lipids that they encode interact with GPCRs that regulate gastrointestinal tract physiology. Mouse and cell-based models demonstrate that commensal GPR119 agonists regulate metabolic hormones and glucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiological role in humans. Our results suggest that chemical mimicry of eukaryotic signalling molecules may be common among commensal bacteria and that manipulation of microbiota genes encoding metabolites that elicit host cellular responses represents a possible small-molecule therapeutic modality (microbiome-biosynthetic gene therapy).


Proceedings of the National Academy of Sciences of the United States of America | 2015

Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist

Louis J. Cohen; Hahk-Soo Kang; John Chu; Yun-Han Huang; Emma A. Gordon; Boojala Vijay B. Reddy; Melinda A. Ternei; Jeffrey W. Craig; Sean F. Brady

Significance In this study, we demonstrate a method for rapidly identifying bacterial effector genes and gene products from human commensal bacteria. Identification of specific effector genes and small molecules improves our understanding of how bacteria might interact with human cells and contribute to both health and disease. The small molecules we isolated, N-acyl-3-hydroxyglycines, resemble endogenously produced N-acyl-amide signaling molecules and were found to activate the human G-protein–coupled receptor (GPCR) GPR132/G2A. G2A has potentially important implications for autoimmune disease and atherosclerosis. Finding commensal small molecules that appear to structurally mimic host signaling metabolites provides greater insight into how commensal bacteria may interact with human physiology and the methods required for future discovery of other commensal effectors. The trillions of bacteria that make up the human microbiome are believed to encode functions that are important to human health; however, little is known about the specific effectors that commensal bacteria use to interact with the human host. Functional metagenomics provides a systematic means of surveying commensal DNA for genes that encode effector functions. Here, we examine 3,000 Mb of metagenomic DNA cloned from three phenotypically distinct patients for effectors that activate NF-κB, a transcription factor known to play a central role in mediating responses to environmental stimuli. This screen led to the identification of 26 unique commensal bacteria effector genes (Cbegs) that are predicted to encode proteins with diverse catabolic, anabolic, and ligand-binding functions and most frequently interact with either glycans or lipids. Detailed analysis of one effector gene family (Cbeg12) recovered from all three patient libraries found that it encodes for the production of N-acyl-3-hydroxypalmitoyl-glycine (commendamide). This metabolite was also found in culture broth from the commensal bacterium Bacteroides vulgatus, which harbors a gene highly similar to Cbeg12. Commendamide resembles long-chain N-acyl-amides that function as mammalian signaling molecules through activation of G-protein–coupled receptors (GPCRs), which led us to the observation that commendamide activates the GPCR G2A/GPR132. G2A has been implicated in disease models of autoimmunity and atherosclerosis. This study shows the utility of functional metagenomics for identifying potential mechanisms used by commensal bacteria for host interactions and outlines a functional metagenomics-based pipeline for the systematic identification of diverse commensal bacteria effectors that impact host cellular functions.


Journal of the American Chemical Society | 2017

Directed γ-C(sp3)–H Alkylation of Carboxylic Acid Derivatives through Visible Light Photoredox Catalysis

Dian-Feng Chen; John Chu; Tomislav Rovis

Visible light photoredox catalysis enables direct γ- C(sp3)-H alkylation of saturated aliphatic carbonyl compounds. Electron-deficient alkenes are used as the coupling partners in this reaction. Distinguished site selectivity is controlled by the predominant 1,5-hydrogen atom transfer of an amidyl radical generated in situ.


Journal of the American Chemical Society | 2015

Zn-catalyzed enantio- and diastereoselective formal [4 + 2] cycloaddition involving two electron-deficient partners: asymmetric synthesis of piperidines from 1-azadienes and nitro-alkenes.

John Chu; Derek M. Dalton; Tomislav Rovis

We report a catalytic asymmetric synthesis of piperidines through [4 + 2] cycloaddition of 1-azadienes and nitro-alkenes. The reaction uses earth abundant Zn as catalyst and is highly diastereo- and regioselective. A novel BOPA ligand (F-BOPA) confers high reactivity and enantioselectivity in the process. The presence of ortho substitution on the arenes adjacent to the bis(oxazolines) was found to be particularly impactful, due to limiting the undesired coordination of 1-azadiene to the Lewis acid and thus allowing the reaction to be carried out at lower temperature. A series of secondary kinetic isotope effect studies using a range of ligands implicates a stepwise mechanism for the transformation, involving an initial Michael-type addition of the imine to the nitro-alkene followed by a cyclization event. The stepwise mechanism obviates the electronic requirement inherent to a concerted mechanism, explaining the successful cycloaddition between two electron-deficient partners.


Journal of the American Chemical Society | 2015

Enantioselective rhodium-catalyzed isomerization of 4-iminocrotonates: asymmetric synthesis of a unique chiral synthon.

Wen-Zhen Zhang; John Chu; Kevin M. Oberg; Tomislav Rovis

An enantioselective isomerization of 4-iminocrotonates catalyzed by a rhodium(I)/phosphoramidite complex is described. This reaction uses widely available amines to couple with 4-oxocrotonate to provide a convenient access to a central chiral building block in good yield and high enantioselectivity. Although the mechanism of this new transformation remains unclear, both Rh and the phosphoramidite play a central role.


Journal of the American Chemical Society | 2017

Antimicrobials Inspired by Nonribosomal Peptide Synthetase Gene Clusters

Xavier Vila-Farres; John Chu; Daigo Inoyama; Melinda A. Ternei; Christophe Lemetre; Louis J. Cohen; Wooyoung Cho; Boojala Vijay B. Reddy; Henry A. Zebroski; Joel S. Freundlich; David S. Perlin; Sean F. Brady

Bacterial culture broth extracts have been the starting point for the development of numerous therapeutics. However, only a small fraction of bacterial biosynthetic diversity is accessible using this strategy. Here, we apply a discovery approach that bypasses the culturing step entirely by bioinformatically predicting small molecule structures from the primary sequences of the biosynthetic gene clusters. These structures are then chemically synthesized to give synthetic-bioinformatic natural products (syn-BNPs). Using this approach, we screened syn-BNPs inspired by nonribosomal peptide synthetases against microbial pathogens, and discovered an antibiotic for which no resistance could be identified and an antifungal agent with activity against diverse fungal pathogens.


Nature | 2018

Corrigendum: Commensal bacteria make GPCR ligands that mimic human signalling molecules

Louis J. Cohen; Daria Esterhazy; Seong-Hwan Kim; Christophe Lemetre; Rhiannon R. Aguilar; Emma A. Gordon; Amanda J. Pickard; Justin R. Cross; Ana B. Emiliano; Sun M. Han; John Chu; Xavier Vila-Farres; Jeremy Kaplitt; Aneta Rogoz; Paula Y. Calle; Craig P. Hunter; J. Kipchirchir Bitok; Sean F. Brady

This corrects the article DOI: 10.1038/nature23874


ACS Infectious Diseases | 2018

Human Microbiome Inspired Antibiotics with Improved β-Lactam Synergy against MDR Staphylococcus aureus

John Chu; Xavier Vila-Farres; Daigo Inoyama; Ricardo Gallardo-Macias; Mark Jaskowski; Shruthi Satish; Joel S. Freundlich; Sean F. Brady

The flippase MurJ is responsible for transporting the cell wall intermediate lipid II from the cytoplasm to the outside of the cell. While essential for the survival of bacteria, it remains an underexploited target for antibacterial therapy. The humimycin antibiotics are lipid II flippase (MurJ) inhibitors that were synthesized on the basis of bioinformatic predictions derived from secondary metabolite gene clusters found in the human microbiome. Here, we describe an SAR campaign around humimycin A that produced humimycin 17S. Compared to humimycin A, 17S is a more potent β-lactam potentiator, has a broader spectrum of activity, which now includes both methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant Enterococcus faecalis (VRE), and did not lead to any detectable resistance when used in combination with a β-lactam. Combinations of β-lactam and humimycin 17S provide a potentially useful long-term MRSA regimen.

Collaboration


Dive into the John Chu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Louis J. Cohen

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar

Tomislav Rovis

Colorado State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emma A. Gordon

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar

Amanda J. Pickard

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Boojala Vijay B. Reddy

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge